Professional Certificate in Pharmacoepidemiology & Pharmacovigilance
Short course
In London
Description
-
Type
Short course
-
Location
London
-
Class hours
300h
-
Duration
Flexible
The global health challenge of maximising drug safety yet maintaining public confidence has become increasingly complex. Pharmaceutical companies are required to employ named members of staff responsible for pharmacovigilance. NGOs need to have confidence that the medicines and products that they provide to communities are both effective and safe. Health authorities grapple with the need to provide quality care whilst containing a burgeoning drug budget. Regulatory authorities must balance the potential benefits of new drugs with varying levels of suspicion of their potential harm.
This 30-week examined training in pharmacoepidemiology and pharmacovigilance addresses the increasing need for well informed professionals to work in all areas related to the assessment of drug safety and risk-benefit of drug use.
It is an introductory course and should meet the needs of a wide variety of practitioners. The variety of backgrounds and the knowledge possessed by lecturers ensures that the course has a sound mixture of the theoretical and the practical issues surrounding drug safety.
Starting from the 2019/2020 intake, as well as including core epidemiology topics and sessions on global and UK pharmacovigilance, the course will include a number of additional dedicated Focus on Europe sessions. These will be led by renowned experts in EU pharmacovigilance and pharmacoepidemiology, and will ensure that the content of the course remains of utmost relevance to those working in the EU.
Facilities
Location
Start date
Start date
About this course
The aim of this well established training programme is to equip students with a basic understanding of the concepts and practice of pharmacoepidemiology and pharmacovigilance. By the end of the programme, students should be able to:
demonstrate an understanding of, and critically evaluate, issues surrounding the risks and benefits of drug use in humans including the cause, manifestations and consequences of adverse drug effects (ADEs), the manner of which these are detected and monitored, and the related historic and legal frameworks
be familiar with and compare fundamental statistical, economic and epidemiological concepts and methods
gain an understanding of, and reflect upon, important pharmacoepidemiological concepts and methods and how these methods can be applied to specific drug issues and pharmaceutical risk management
assess and critically analyse the results of pharmacoepidemiological studies (other investigators'), including critical appraisal of the study question, study design, methods and conduct, statistical analyses and interpretation
The course covers aspects of drug development, licensing, surveillance and policy, and is aimed at personnel who are working (or intending to work) on any of these aspects in the following sectors:
the pharmaceutical industry
NGOs
regulatory bodies
health services
health policy decision-making agencies
This course has been approved by the Federation of the Royal Colleges of Physicians of the UK for 30 Category 1 (external) Continuing Professional Development (CPD) credits.
Reviews
Subjects
- Risk
- Staff
- Business Administration
- Teaching
- Sound
- Global
- University
- Public
- Project
- Business and Administration
- IT risk
- Confidence Training
Course programme
The curriculum will provide an introduction to epidemiology, statistics, pharmacoepidemiology and health economics. It will also cover the historical and legal background to pharmacovigilance and pharmacoepidemiology, and pharmacological basis of ADEs, addressing ADE issues at individual and population levels, and the application of pharmacoepidemiological principles and methods to practical drug issues.
Teaching Methods
Teaching will include traditional lectures and seminar/workshops during formal teaching, self-directed learning in between formal teaching and self-directed (but supervised) project work. Workshops will address topics such as designing a pharmacoepidemiological study, critical appraisal of published papers, developing risk management plans and responding to a drug safety alert. The self-directed component will be facilitated by the provision of detailed course material. Students will be provided with a reading list pertinent to the training.
The variety of backgrounds and the knowledge possessed by lecturers ensures that the course has a sound mixture of the theoretical and the practical issues surrounding drug safety. The teachers range from academic staff at the School, with expertise in areas such as pharmacology, epidemiology and statistics, to senior practitioners in the international pharmaceutical industry, regulatory authorities, and public health who have practical expertise in pharmacovigilance and pharmacoepidemiology.
Methods of assessment
The course is examined through unseen written examinations and submission of a written project, the subject of which is determined by the course organiser. All materials for the project will be provided, and each student will be supported by an academic adviser. Additionally two lectures on the chosen topic will be included in the syllabus.
Professional Certificate in Pharmacoepidemiology & Pharmacovigilance